Projects currently studied in the Cardozo Lab are funded through:
- DOD SCIRP
- Synergy Between Exercise and a Connexin Hemichannel Blocker After SCI
- PI: Christopher Cardozo
- Synergy Between Exercise and a Connexin Hemichannel Blocker After SCI
- NYS DOH SCIRB
- Program Support
- PI: Christopher Cardozo
- Program Support
- VA RR&D Service
- Romosozumab to Improve Bone Mineral Density and Architecture in Chronic SCI
- PI: Christopher Cardozo
- Romosozumab to Improve Bone Mineral Density and Architecture in Chronic SCI
- VA RR&D Service
- Non-selective membrane channel blockers for mTBI
- PI: Christopher Cardozo
- Non-selective membrane channel blockers for mTBI
Projects previously studied in the Cardozo Lab were funded through:
- DOD SCIRP SC170315
- Functional and metabolic benefits of inhibiting myostatin activation in conjunction with neuromuscular electrical stimulation
- VA BLR/D1IS1BX005512-01 ShEEP-IC
- Jess Simple Western System
- PI: Christopher Cardozo
- Jess Simple Western System
- VA RR&D B-2313-R
- Role of ryanodine receptor dysfunction after spinal cord injury
- PI: Christopher Cardozo
- Role of ryanodine receptor dysfunction after spinal cord injury
- VA RR&D Service B2649-R
- Testosterone and Long Pulse Width Stimulation for Denervated Muscles after SCI
- DOD SCIRP IIR SC190031
- Synergy Between Exercise and a Connexin Hemichannel Blocker After SCI”
- PI: Christopher Cardozo
- Synergy Between Exercise and a Connexin Hemichannel Blocker After SCI”
- NIA R01AG060341
- Loss of Numb in Muscle Dysfunction
- PI: Dr. Cardozo, Dr. Brotto
- Loss of Numb in Muscle Dysfunction
- NYS SCIRB Contract C34461GG
- Treatment with Romosozumab versus Denosumab to Improve Bone Mineral Density and Architecture in Subacute SCI
- PI: Christopher Cardozo
- Treatment with Romosozumab versus Denosumab to Improve Bone Mineral Density and Architecture in Subacute SCI
- VA ORD ShEEP
- ShEEP Application for a Multimodal Plate Reader